RhineGene, the aspiring biotechnology firm headquartered in the Netherlands, is delighted to announce the latest addition to its family of branches with the establishment in Germany. This expansion marks a significant milestone in RhineGene’s global growth strategy, adding to its existing presence in Bulgaria, Poland, and the Philippines.
Germany has long been at the forefront of scientific advancements, making it an ideal location for RhineGene’s new venture. By tapping into the talent pool and resources available in Germany, RhineGene aims to accelerate its research and development efforts and offer even more innovative solutions to its global customer base.
The new Germany branch will complement the existing network of RhineGene’s global operations, its commitment to driving innovation in the biotechnology sector and its dedication to serving customers worldwide. As an international company committed to excellence, RhineGene places great emphasis on research and development. The addition of the German branch will not only strengthen its research capabilities but also broaden its reach within the European market, positioning RhineGene as a key player in the region’s biotechnology landscape.
RhineGene B.V. extends its warmest welcome to RhineGene Germany and looks forward to a fruitful collaboration that will contribute to advancements in biotechnology for the betterment of society.
For more information about RhineGene and its global network of branches, please visit https://rhinegene.com/.
About RhineGene B.V.
RhineGene B.V. is an international biotechnology firm headquartered in the Netherlands, with a mission to drive innovation and excellence in the field of biotechnology. With established branches in Bulgaria, Poland, the Philippines, and now Germany, RhineGene is at the forefront of delivering cutting-edge biotechnological solutions to a global customer base.
